uniQure Provides FDA Update on AMT-130; BLA Timing Unclear
uniQure (NASDAQ: QURE) on Nov. 3, 2025 announced FDA feedback…
A Gene Therapy ‘First’: Huntington’s Disease Successfully Treated in Early Trial
In an hours-long brain surgery, doctors delivered a new piece of genetic code directly into patients’ brains. Early…